| Patents for C07D 417 - Heterocyclic compounds containing two or more hetero rings, at least one ring having nitrogen and sulfur atoms as the only ring hetero atoms, not provided for by group (62,773) |
|---|
| 07/04/2000 | US6083949 For treating cancer in which raf kinase is implicated, as well as compounds which inhibit, suppress or antagonize the production or activity of cytokines such as interleukins and tumor necrosis factor |
| 07/04/2000 | US6083944 Enzyme inhibitors; treatment of various debilitating disorders |
| 07/04/2000 | US6083942 Pesticidal hetero-substituted oxadiazine compounds |
| 07/04/2000 | US6083881 Pyrazole derivatives as herbicides |
| 07/04/2000 | US6083879 Herbicidal benzoylisothiazoles |
| 07/04/2000 | US6083515 Treating inflammation, pain, gastrointestinal lesions or fever in an animal in need thereof with reduction of the gastrointestinal toxicity or renal toxicity of the nonsteroidal antiinflammatory drug |
| 06/29/2000 | WO2000037473A1 Epothilone derivatives and their use as antitumor agents |
| 06/29/2000 | WO2000037464A2 4-(aminoalkoxy)benzofurans as n-myristoyltransferase inhibitors |
| 06/29/2000 | WO2000037463A1 S-oxide lipid lowering compounds |
| 06/29/2000 | WO2000037461A1 4-(aminomethyl)-piperidine benzamides for treating gastrointestinal disorders |
| 06/29/2000 | WO2000037458A1 Farnesyl protein transferase inhibitors |
| 06/29/2000 | WO2000037107A2 Use of cyclooxygenase-2 inhibitor, a matrix metallaproteinase inhibitor, an antineoplastic agent and optionally radiation as a combination treatment of neoplasia |
| 06/29/2000 | WO2000009112A3 Heterocyclic esters or amides for vision and memory disorders |
| 06/29/2000 | WO1999064034A9 β2-ADRENERGIC RECEPTOR AGONISTS |
| 06/29/2000 | CA2356426A1 Method of using a cyclooxygenase-2 inhibitor and a matrix metalloproteinase inhibitor as a combination therapy in the treatment of neoplasia |
| 06/29/2000 | CA2355822A1 S-oxide lipid lowering compounds |
| 06/29/2000 | CA2355694A1 Novel bicyclic compounds |
| 06/28/2000 | EP1012164A1 Serine protease inhibitors |
| 06/28/2000 | EP1012139A1 AZETIDINONE DERIVATIVES AS $g(b)-LACTAMASE INHIBITORS |
| 06/28/2000 | CN1258288A 1,2,3-thiadiazole derivs. plant disease controlling agent, and method for use thereof |
| 06/28/2000 | CN1258283A Cyclic diamine compounds and medicine contg. same |
| 06/28/2000 | CN1258192A Fungicidal mixtures |
| 06/28/2000 | CN1258191A Antimicrobial prevention and treatment of human immunedeficiency virus and other infectious diseases |
| 06/28/2000 | CN1053905C Oxadiazine derivs., their preparing process and use, intermediates for preparing same |
| 06/27/2000 | US6080869 Chemical reduction process; forming dopamine da2 receptor agonists and beta2 adrenoreceptor agonists for treating obstructive airways diseases |
| 06/27/2000 | US6080868 As a quencher in a reporter-quencher energy-transfer dye pair for nucleic acid hybridization assays |
| 06/27/2000 | US6080772 Thiazole compounds and methods of modulating signal transduction |
| 06/27/2000 | US6080770 Modulators of molecules with phosphotyrosine recognition units |
| 06/27/2000 | US6080767 Substituted n-[(aminoiminomethyl or aminomethyl)phenyl]propyl amides |
| 06/27/2000 | US6080764 Superoxide radical inhibitor |
| 06/27/2000 | US6080758 Analgesics, antiinflammatory agents; asthma; allergic rhinitis |
| 06/27/2000 | US6080743 2,3-dioxo-1,2,3,4-tetrahydro-quinoxalinyl derivatives |
| 06/27/2000 | CA2198564C Method of reducing tissue damage associated with non-cardiac ischemia |
| 06/27/2000 | CA2017193C N-(aryloxyalkyl)heteroarylpiperidines and-heteroarylpiperazines, a pro cess for their preparation and their use as medicaments |
| 06/22/2000 | WO2000035917A1 1,4-benzodiazepinone derivatives and their use as integrin antagonists |
| 06/22/2000 | WO2000035915A1 Piperazine derivatives |
| 06/22/2000 | WO2000035912A1 4-trifluoromethyl-3-oxazolylpyridines, method for producing them, products containing the same, and their use as pesticides |
| 06/22/2000 | WO2000035903A2 Thiochromanoyl cyclohexenone derivatives |
| 06/22/2000 | WO2000035886A2 (hetero)aryl-bicyclic heteroaryl derivatives, their preparation and their use as protease inhibitors |
| 06/22/2000 | WO2000035877A1 Heterocyclic piperidines as modulators of chemokine receptor activity |
| 06/22/2000 | WO2000035864A1 New biphenyl and biphenyl-analogous compounds as integrin antagonists |
| 06/22/2000 | WO2000035454A1 N-ureidoalkyl-piperidines as modulators of chemokine receptor activity |
| 06/22/2000 | WO2000035453A1 N-ureidoalkyl-piperidines as modulators of chemokine receptor activity |
| 06/22/2000 | WO2000035452A1 N-ureidoalkyl-piperidines as modulators of chemokine receptor activity |
| 06/22/2000 | WO2000035451A1 N-ureidoalkyl-piperidines as modulators of chemokine receptor activity |
| 06/22/2000 | WO2000035449A1 N-ureidoalkyl-piperidines as modulators of chemokine receptor activity |
| 06/22/2000 | WO2000035437A2 Improving mental performance by increasing brain insulin sensitivity |
| 06/22/2000 | WO2000035285A1 4-haloalkyl-3-heterocyclylpyridines and 4-haloalkyl-5-heterocyclyl-pyrimidines and their use as repellents |
| 06/22/2000 | CA2355645A1 Increasing brain glucose utilization |
| 06/22/2000 | CA2355249A1 Protease inhibitors |
| 06/22/2000 | CA2355161A1 Biphenyl and biphenyl-analogous compounds as integrin antagonists |
| 06/22/2000 | CA2355125A1 Thiochromanoylcyclohexenone derivatives |
| 06/22/2000 | CA2354875A1 Piperazine derivatives |
| 06/22/2000 | CA2353897A1 1,4-benzodiazepinone derivatives and their use as integrin antagonists |
| 06/22/2000 | CA2350730A1 N-ureidoalkyl-piperidines as modulators of chemokine receptor activity |
| 06/22/2000 | CA2348923A1 N-ureidoalkyl-piperidines as modulators of chemokine receptor activity |
| 06/22/2000 | CA2347912A1 Heterocyclic piperidines as modulators of chemokine receptor activity |
| 06/22/2000 | CA2347909A1 N-ureidoalkyl-piperidines as modulators of chemokine receptor activity |
| 06/22/2000 | CA2347770A1 N-ureidoalkyl-piperidines as modulators of chemokine receptor activity |
| 06/22/2000 | CA2346933A1 N-ureidoalkyl-piperidines as modulators of chemokine receptor activity |
| 06/21/2000 | EP1009743A1 Certain benzothiazine dioxide endothelin antagonists and processes for their preparation |
| 06/21/2000 | EP1009738A1 Substituted oxindole derivatives as protein tyrosine kinase and as protein serine/threonine kinase inhibitors |
| 06/21/2000 | EP1009405A1 Pyrrolidine and piperidine modulators of chemokine receptor activity |
| 06/21/2000 | DE19858192A1 4-Trifluormethyl-3-oxazolylpyridine, Verfahren zu ihrer Herstellung, sie enthaltende Mittel und ihre Verwendung als Schädlingsbekämpfungsmittel 4-trifluoromethyl-3-oxazolylpyridine, processes for their preparation, compositions containing them and their use as pesticides |
| 06/21/2000 | DE19858191A1 4-Haloalkyl-3-heterocyclylpyridine und 4-Haloalkyl-5-heterocyclyl-pyrimidine und ihre Verwendung als Repellentien 4-haloalkyl-3-heterocyclylpyridine and 4-haloalkyl-5-heterocyclyl-pyrimidines and their use as repellents |
| 06/21/2000 | CN1257498A Pyridylthio-dithiazole derivatives and their use as pest control agent |
| 06/21/2000 | CN1257486A Oxazolidinone antibacterial agents having a thiocarbonyl functionality |
| 06/21/2000 | CN1053668C Novel compound, process for preparing same and antitumor agent |
| 06/21/2000 | CN1053657C Didepside phthaleins based internal parasite compositions, novel didepside phthaleins and preparation process thereof |
| 06/20/2000 | US6077853 Inhibitors of farnesyl-protein transferase |
| 06/20/2000 | US6077813 Substituted aromatic thiocarboxylic acid amides and their use as herbicides |
| 06/15/2000 | WO2000034271A1 Method for producing pyrazolylbenzoyl derivatives and novel pyrazolylbenzoyl derivatives |
| 06/15/2000 | WO2000034269A1 Thiourea inhibitors of herpes viruses |
| 06/15/2000 | WO2000034268A1 Thiourea inhibitors of herpes viruses |
| 06/15/2000 | WO2000034258A2 Heterocyclic carboxamide-containing thiourea inhibitors of herpes viruses containing phenylenediamine group |
| 06/15/2000 | WO2000034257A1 Substituted 2-imino-thiazolines and their use as herbicides |
| 06/15/2000 | WO2000034256A1 Substituted 2-imino-thiazolines |
| 06/15/2000 | WO2000033842A1 Myt1 kinase inhibitors |
| 06/15/2000 | WO2000033841A1 Myt1 kinase inhibitors |
| 06/15/2000 | WO2000033837A2 Myt1 kinase inhibitors |
| 06/15/2000 | WO2000009107A3 Sulfonamides of n-containing heterocyclic thioesters for vision and memory disorders |
| 06/15/2000 | DE19856966A1 Substituierte 2-Imino-thiazoline Substituted 2-imino-thiazolines |
| 06/15/2000 | DE19856965A1 Substituierte 2-Imino-thiazoline Substituted 2-imino-thiazolines |
| 06/15/2000 | DE19856439A1 Verfahren zur Herstellung von Dithiazolyldisulfiden A process for preparing Dithiazolyldisulfiden |
| 06/15/2000 | CA2353572A1 Method for producing pyrazolylbenzoyl derivatives and novel pyrazolylbenzoyl derivatives |
| 06/15/2000 | CA2351390A1 Thiourea inhibitors of herpes viruses |
| 06/15/2000 | CA2350996A1 Thiourea inhibitors of herpes viruses |
| 06/15/2000 | CA2350767A1 Heterocyclic carboxamide-containing thiourea inhibitors of herpes viruses containing phenylenediamine group |
| 06/14/2000 | EP1008591A1 Process for the preparation of dithiazolyldisulfides |
| 06/14/2000 | EP1007525A1 Aminometyl oxooxazolidinyl benzene derivatives |
| 06/14/2000 | EP1007524A1 Indole derivatives as 5-ht1b and 5-ht1d agonists |
| 06/14/2000 | EP1007515A1 Arylpyridazinones as prostaglandin endoperoxide h synthase biosynthesis inhibitors |
| 06/14/2000 | EP1007513A1 Pesticidal 1-aryl-3-iminopyrazoles |
| 06/14/2000 | EP1007042A1 Novel heteroaryl compounds for the modulation of protein tyrosine enzyme related cellular signal transduction |
| 06/14/2000 | EP1006794A1 A method for treating or preventing alzheimer's disease |
| 06/14/2000 | CN1053448C Compound useful as antiproliferative agents and GARFT inhibitors |
| 06/13/2000 | US6075040 Obesity and diabetes |
| 06/13/2000 | US6075038 Alpha 1a adrenergic receptor antagonists |
| 06/13/2000 | US6075019 Arylthio-dithiazindioxides and their use as pesticides |
| 06/13/2000 | US6075016 6,5-fused aromatic ring systems having enhanced phosphodiesterase IV inhibitory activity |